A Study to Compare the Efficacy of SEL-212 to KRYSTEXXA® in Gout Participants Refractory to Conventional Therapy
Clinical trial NCT03905512 · COMPLETED
Trial details
- NCT number
- NCT03905512
- Sponsor
- Selecta Biosciences, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-07
- Primary completion
- 2020-08-05
- Enrollment
- 170
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.